Gemcitabine and cisplatin treatment over a 3-week versus a 4-week dosing schedule: a randomized trial conducted in Chinese patients with nonsmall cell lung cancer

Mei-lin LIAO; Yun-zhong ZHU; Long-yun LI; Huan-ying WAN; Shi-ying YU; Belinda HALL; Teena WEST; Li WANG.
Chinese Medical Journal ; (24): 892-897, 2008.
Artículo en Inglés | WPRIM | ID: wpr-258570

Documentos relacionados

  1. Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.
  2. The biochemistry of disease: desperately seeking syzygy.
  3. Aortite chez une patiente recevant une chimiothérapie.
  4. Evaluating automated entity extraction with respect to drug and non-drug treatment strategies.
  5. [Dissonance in addictology - The missed encounter between Laszlo Levendel and Thomas Szasz].
  6. Anything you can do I can do better.
  7. [Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders].
  8. Communication in Drug Development: "Translating" Scientific Discovery.
  9. RNA-based therapeutics: ready for delivery?
  10. Prediction of drug's Anatomical Therapeutic Chemical (ATC) code by integrating drug-domain network.